After Reading This Article You Can Solve This UPSC Mains Model Question:
India’s status as the ‘Pharmacy of the World’ depends not only on affordable medicines but also on robust regulatory oversight. Discuss the challenges facing pharmaceutical regulation in India and the reforms required to address them. 15 Marks (GS-2, Governance)
Why in News?
The Union Health Ministry has amended the Drugs Rules, 1945 by removing “syrup” from Schedule K, making cough syrups prescription-only medicines. The move comes in response to the deaths of over 300 children abroad due to contaminated India-made cough syrups, WHO warnings on drug quality, and growing concerns over weaknesses in India’s pharmaceutical regulatory framework.
Introduction
India, often called the “Pharmacy of the World”, is a leading supplier of affordable medicines globally. However, recent deaths linked to contaminated India-made cough syrups have exposed gaps in drug quality control and regulatory oversight, highlighting the need for stronger pharmaceutical governance beyond merely restricting OTC sales.
Significance of the Pharmaceutical Industry in India
1. Economic Significance
- Largest supplier of generic medicines: India meets a significant share of the world’s demand for affordable generic drugs.
- 20% of global generic exports: India accounts for nearly one-fifth of global generic medicine exports by volume.
- Boosts exports and employment: The sector is a major contributor to foreign exchange earnings and provides employment across the value chain.
2. Public Health Significance
- Affordable healthcare worldwide: India exports affordable medicines to over 200 countries, making essential healthcare accessible globally and reinforcing its role as a major supplier of generic drugs. The top importers of Indian pharmaceuticals include the USA, UK, Brazil, France, and South Africa.
- Critical during COVID-19: Through the Vaccine Maitri initiative, India supplied over 300 million vaccine doses to more than 100 countries, strengthening global health security and India’s health diplomacy.
3. Strategic Significance
- Enhances health diplomacy: Pharmaceutical exports strengthen India’s relations with partner countries through medical assistance.
- Supports healthcare hub ambitions: A strong pharma sector is vital for India’s goal of becoming a global healthcare and biotechnology leader.
4. Global Reputation
- “Pharmacy of the Global South”: India is trusted by many developing nations as a reliable source of affordable medicines.
- Impacts global health security: The quality and safety of Indian medicines have direct implications for public health across the world.
Core Issues in Pharmaceutical Safety and Rationale Behind Restricting Cough Syrups
1. Contaminated Raw Materials
The presence of toxic substances such as ethylene glycol (EG) and diethylene glycol (DEG) in drug ingredients has caused fatal health consequences.
2. Weak Manufacturing Practices
Poor compliance with Good Manufacturing Practices (GMP) and cost-cutting measures compromise drug quality and safety.
3. Inadequate Quality Testing
Failure to rigorously test raw materials and finished products allows contaminated medicines to enter the market.
4. Regulatory Oversight Deficit
Weak inspections, poor enforcement, and limited accountability reduce the effectiveness of drug regulation.
5. Health Risks from OTC Cough Syrups
Many cough syrups contain antihistamines, bronchodilators, and decongestants that can cause sedation, tremors, and cardiovascular side effects.
6. Irrational Use and Self-Medication
Prescription-only sales can reduce misuse of cough syrups, discourage self-medication, and promote consultation with qualified healthcare professionals.
Challenges in India’s Pharmaceutical Regulatory Framework
1. Weak Regulatory Capacity
India’s drug regulatory system suffers from inadequate manpower, limiting effective inspection, monitoring, and surveillance of pharmaceutical units.
2. Fragmented Governance
The division of regulatory responsibilities between the Centre and States leads to inconsistent enforcement and coordination gaps.
3. Inadequate Testing Infrastructure
A shortage of modern accredited laboratories hampers timely and accurate quality testing of medicines.
4. Industry Resistance
Concerns over higher compliance costs often lead some manufacturers to oppose stricter quality-control and testing requirements.
5. Poor Enforcement
Weak inspections and lenient penalties reduce deterrence and allow regulatory violations to persist.
6. Prevalence of OTC Culture
Widespread self-medication and reliance on pharmacists for primary healthcare contribute to irrational drug use and misuse of medicines.
Implications of Weak Pharmaceutical Regulation
A. Domestic Implications
1. Public Health Risks
The circulation of substandard or contaminated medicines can result in serious adverse reactions, treatment failures, and even fatalities. This increases the overall disease burden and undermines public health outcomes.
2. Erosion of Public Trust
Repeated incidents of poor-quality medicines weaken citizens’ confidence in healthcare systems and regulatory institutions. Such distrust may discourage patients from adhering to prescribed treatments.
3. Economic Costs
Drug safety failures increase healthcare expenditure due to additional treatment, hospitalization, and monitoring requirements. They also expose pharmaceutical companies and governments to legal liabilities and compensation claims.
B. International Implications
4. Damage to India’s Reputation
Quality lapses tarnish India’s image as the “Pharmacy of the World” and raise concerns about the reliability of its pharmaceutical products. For example, the 2023 contaminated eye-drop crisis led to deaths and permanent vision loss, following which the U.S. FDA placed the Indian manufacturer on an import alert, affecting India’s pharmaceutical credibility.
5. Threat to Pharmaceutical Exports
Importing countries may impose stricter quality checks, regulatory barriers, or product bans on Indian medicines. Such measures can reduce export earnings and adversely affect the pharmaceutical industry’s growth.
6. Global Health Concerns
Since Indian medicines are supplied worldwide, quality failures can endanger public health across multiple countries. Weak regulation in a major drug-exporting nation can therefore become a global health security challenge.
Key Reform Recommendations by Various Committees and Policies
1. Mashelkar Committee (2003)
Recommended a professionally managed and centrally coordinated drug regulatory system to ensure uniform quality standards across India.
2. Ranjit Roy Chaudhury Expert Committee (2013)
Advocated greater autonomy, transparency, and scientific capacity for CDSCO to improve the efficiency and credibility of drug regulation.
3. Parliamentary Standing Committee on Health (59th Report, 2012)
Called for a comprehensive overhaul of the drug approval process by addressing conflicts of interest and strengthening regulatory oversight.
4. National Health Policy (2017)
Emphasised stronger regulatory mechanisms, modern testing infrastructure, and robust quality assurance to ensure safe and effective medicines.
Way Forward
1. Strengthen Quality Control Mechanisms
Mandatory testing of raw materials, adoption of advanced analytical technologies, and independent third-party audits can help ensure the safety and quality of medicines before they reach consumers.
2. Enhance Regulatory Capacity
Recruiting more drug inspectors, improving technical training, and strengthening State Drug Control Departments will enable more effective monitoring and enforcement of pharmaceutical standards.
3. Modernise Testing Infrastructure
Establishing well-equipped laboratories across states and implementing digital batch-tracking systems can improve the speed, accuracy, and traceability of quality assessments.
4. Improve Enforcement
Risk-based inspections, stringent penalties for violations, and criminal liability in cases of serious negligence can create a strong deterrent against non-compliance.
5. Strengthen Pharmacovigilance
Robust adverse drug reaction reporting systems and real-time surveillance mechanisms can help detect and address drug safety issues at an early stage.
6. Undertake Regulatory Reforms
Better coordination between CDSCO and State regulators, along with a more integrated regulatory framework, can ensure uniform standards and greater accountability.
7. Promote Responsible Drug Use
Public awareness campaigns against self-medication and stricter enforcement of prescription norms can encourage rational and safe use of medicines.
Conclusion
For a nation that supplies medicines to the world, drug safety is not merely a regulatory obligation but a strategic imperative. India’s pharmaceutical success must rest not only on affordability and scale but equally on quality, trust and accountability.